Soumit Roy
Stock Analyst at Jones Trading
(1.48)
# 3,193
Out of 4,712 analysts
28
Total ratings
18.18%
Success rate
-6.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRVO CervoMed | Downgrades: Hold | n/a | $2.22 | - | 2 | Dec 10, 2024 | |
| EPIX ESSA Pharma | Downgrades: Hold | n/a | $1.61 | - | 1 | Nov 1, 2024 | |
| ELTX Elicio Therapeutics | Initiates: Buy | $9 | $5.24 | +71.76% | 1 | Oct 31, 2024 | |
| ELVN Enliven Therapeutics | Initiates: Buy | $36 | $23.15 | +55.51% | 1 | Oct 31, 2024 | |
| ORIC ORIC Pharmaceuticals | Initiates: Buy | $17 | $8.19 | +107.57% | 1 | Oct 31, 2024 | |
| BEAM Beam Therapeutics | Initiates: Hold | n/a | $28.81 | - | 1 | Sep 17, 2024 | |
| EDIT Editas Medicine | Initiates: Buy | $13 | $1.21 | +974.38% | 1 | Sep 17, 2024 | |
| ACET Adicet Bio | Maintains: Buy | $6 → $4 | $0.92 | +336.59% | 2 | Sep 11, 2024 | |
| INAB IN8bio | Downgrades: Hold | n/a | $0.23 | - | 3 | Aug 12, 2024 | |
| SAVA Cassava Sciences | Downgrades: Hold | n/a | $2.34 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.51 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $12.27 | +111.90% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $56.14 | +24.69% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $22.05 | -54.65% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $6.23 | +317.34% | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.97 | +827.84% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $0.14 | +2,716.90% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.96 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $0.40 | +1,910.05% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $4.50 | +17,900.00% | 1 | Feb 24, 2021 |
CervoMed
Dec 10, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.22
Upside: -
ESSA Pharma
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.61
Upside: -
Elicio Therapeutics
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $5.24
Upside: +71.76%
Enliven Therapeutics
Oct 31, 2024
Initiates: Buy
Price Target: $36
Current: $23.15
Upside: +55.51%
ORIC Pharmaceuticals
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $8.19
Upside: +107.57%
Beam Therapeutics
Sep 17, 2024
Initiates: Hold
Price Target: n/a
Current: $28.81
Upside: -
Editas Medicine
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $1.21
Upside: +974.38%
Adicet Bio
Sep 11, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.92
Upside: +336.59%
IN8bio
Aug 12, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.23
Upside: -
Cassava Sciences
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.34
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.51
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $12.27
Upside: +111.90%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $56.14
Upside: +24.69%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $22.05
Upside: -54.65%
Aug 18, 2023
Initiates: Buy
Price Target: $26
Current: $6.23
Upside: +317.34%
May 24, 2023
Initiates: Buy
Price Target: $9
Current: $0.97
Upside: +827.84%
Apr 19, 2023
Initiates: Buy
Price Target: $4
Current: $0.14
Upside: +2,716.90%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.96
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $8
Current: $0.40
Upside: +1,910.05%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $4.50
Upside: +17,900.00%